Systemic Sclerosis
Rare Diseases of the Immune System, ISSN: 2283-6403, Vol: Part F3423, Page: 105-126
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Systemic sclerosis (SSc) is a connective tissue disease characterized by fibrosis clinically evident in the skin (scleroderma), but which may also occur in other organs or systems. Fibrosis is the final stage of a pathogenetic process triggered by functional and structural alterations of the microcirculation encompassing platelet activation and dysregulation of the immune response. SSc affects the skin, blood vessels, musculoskeletal system, and internal organs (gastrointestinal tract, lungs, heart, kidneys). Visceral involvement is responsible for significant morbidity and mortality in SSc patients [1, 2].
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85204953261&origin=inward; http://dx.doi.org/10.1007/978-3-031-60855-1_6; https://link.springer.com/10.1007/978-3-031-60855-1_6; https://dx.doi.org/10.1007/978-3-031-60855-1_6; https://link.springer.com/chapter/10.1007/978-3-031-60855-1_6
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know